Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2/FAK/Src signaling pathway
Qingxiu Zhang, Tao Ran, Shiliang Li, Lu Han, Shaojie Chen, Guoyuan Lin, Huayue Wu, Huan Wu, Shu Feng, Jiyu Chen, Qian Zhang, Xueke Zhao
Topics & Concepts
EPH receptor A2Proto-oncogene tyrosine-protein kinase SrcLiver fibrosisAnaerobic glycolysisCatalpolChemistrySignal transductionCancer researchCell biologyPharmacologyFibrosisGlycolysisMedicineBiochemistryBiologyInternal medicineEnzymeGlycosideReceptor tyrosine kinaseOrganic chemistryLiver physiology and pathologyPhytochemistry and Biological ActivitiesLiver Disease Diagnosis and Treatment